Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2019

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______to______

Commission File Number: 000-55862

Bakhu Holdings Corp.

(Exact name of registrant as specified in its Charter)

Nevada		26-0510649
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employee Identification No.)

24328 Vermont Avenue, Suite 300 Harbor City, California		90710
(Address of principal executive office)		(Zip Code)

(310) 891-1959

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer (Do not check if smaller reporting company)	☐	Smaller reporting company	☒

Table of Contents

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: As of March 21, 2019, there were 281,938,184 shares of $0.001 par value common stock, issued and outstanding.

Table of Contents

TABLE OF CONTENTS

PART I: FINANCIAL INFORMATION

Item 1: Financial Statements	4
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operation	10
Item 3: Quantitative and Qualitative Disclosures about Market Risk	12
Item 4: Controls and Procedures	12

PART II: OTHER INFORMATION

Item 1: Legal Proceedings	13
Item 1A: Risk Factors	13
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds	13
Item 3: Defaults Upon Senior Securities	13
Item 4: Mine Safety Disclosures	13
Item 5: Other Information	13
Item 6: Exhibits	13

SIGNATURES	14

Table of Contents

BAKHU HOLDINGS, CORP.
Balance Sheets

ASSETS

	January 31,			July 31,
	2019			2018
	(Unaudited)

CURRENT ASSETS

Cash and cash equivalents	$	—		$	13,138

Total Current Assets		—			13,138

TOTAL ASSETS	$	—		$	13,138


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES

Accounts payable	$	—		$	13,000
Accrued interest		1,371			702
Short term borrowings - related parties		130,692			8,829

Total Current Liabilities		132,063			22,531

TOTAL LIABILITIES		132,063			22,531

STOCKHOLDERS' EQUITY (DEFICIT)

Preferred stock, $0.001 par value; 50,000,000 shares authorized,
4 and -0- shares issued and outstanding, respectively		—			—
Common stock, $0.001 par value; 500,000,000 shares authorized,
71,938,184 and 71,938,184 shares issued and outstanding, respectively		71,938			71,938
Additional paid-in capital		3,884,787			3,884,787
Accumulated deficit		(4,088,788	)		(3,966,118	)

Total Stockholders' Equity (Deficit)		(132,063	)		(9,393	)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	—		$	13,138

The accompanying notes are an integral part of these financial statements.

Table of Contents

BAKHU HOLDINGS, CORP.
Statements of Operations
(Unaudited)

	For the Three Months Ended						For the Six Months Ended
	January 31,						January 31,
	2019			2018			2019			2018

NET REVENUES	$	—		$	—		$	—		$	—

OPERATING EXPENSES

Professional and consulting fees		—			26,170			83,155			106,890
Selling, general and administrative		—			2,350			38,847			1,726

Total Operating Expenses		—			28,520			122,002			108,616

LOSS FROM OPERATIONS		—			(28,520	)		(122,002	)		(108,616	)

OTHER INCOME (EXPENSES)

Interest expense		(334	)		(6,625	)		(668	)		(7,890	)

Total Other Income (Expenses)		(334	)		(6,625	)		(668	)		(7,890	)

LOSS BEFORE INCOME TAXES		(334	)		(35,145	)		(122,670	)		(116,506	)

PROVISION FOR INCOME TAXES		—			—			—			—

NET LOSS	$	(334	)	$	(35,145	)	$	(122,670	)	$	(116,506	)

BASIC NET LOSS PER SHARE	$	(0.00	)	$	(0.14	)	$	(0.00	)	$	(0.45	)

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING		71,938,184			260,037			71,938,184			260,037

The accompanying notes are an integral part of these financial statements.

Table of Contents

BAKHU HOLDINGS, CORP.
Statements of Cash Flows
(Unaudited)

	For the Six Months Ended
	January 31,
	2019			2018

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss	$	(122,670	)	$	(116,506	)
Adjustments to reconcile net loss to net cash
used by operating activities:
Amortization of debt discount		—			7,140
Changes in operating assets and liabilities:
Accounts payable		(13,000	)		85,303
Accrued liabilities		669			750

Net Cash Used by Operating Activities		(135,001	)		(23,313	)

CASH FLOWS FROM INVESTING ACTIVITIES		—			—

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from short term borrowings - related parties		121,863			—
Payments on short term financings from Somerset Private Fund, Ltd		—			(759	)
Proceeds from Receiver notes payable provided by third parties		—			25,000

Net Cash Provided by Financing Activities		121,863			24,241

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(13,138	)		928

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		13,138			98

CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	—		$	1,026

SUPPLEMENTAL DISCLOSURES:

Cash paid for interest	$	—		$	—
Cash paid for income taxes	$	—		$	—

The accompanying notes are an integral part of these financial statements.

Table of Contents

BAKHU HOLDINGS, CORP.

Notes to The Financial Statements

January 31, 2019

(Unaudited)

1. ORGANIZATION AND BUSINESS OPERATIONS

Planet Resources, Corp (“the Company”) was incorporated under the laws of the State of Nevada, U.S. on April 24, 2008. In May 2009 the Company also began to look for other types of business to pursue that would benefit the shareholders. In order to pursue businesses that may not be in the mining industry the name of the Company was changed with the approval of the Directors and Shareholders to Bakhu Holdings, Corp. on May 4, 2009 (“Bakhu, or the “Company”).

The Company has not generated any revenue to date and consequently its operations are subject to all risks inherent in the establishment of a new business enterprise. For the period from inception, April 24, 2008 through January 31, 2019 the Company has accumulated losses of $4,088,788.

Reverse Stock Split

On January 12, 2018 the Company effected a 1 for 200 reverse split of the Company’s issued and outstanding common stock which reduced the outstanding shares from approximately 45,000,000 shares to 260,037 shares outstanding. In connection with the split, any shareholder who owned shares as of the record date and would have received less than 100 post-split shares after effecting the split, received 100 post-split shares. Accordingly, all references to the numbers of common shares and per share data in the accompanying financial statements have been adjusted to reflect this retroactive split on a retroactive basis, unless indicated otherwise.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a) Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.

b) Going Concern

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of $4,088,788 as of January 31, 2019 and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern.

c) Cash and Cash Equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents.

d) Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

e) Foreign Currency Translation

The Company’s functional currency and its reporting currency is the United States dollar.

f) Financial Instruments

The carrying value of the Company’s financial instruments approximates their fair value because of the short maturity of these instruments.

Table of Contents

BAKHU HOLDINGS, CORP.

Notes to The Financial Statements

January 31, 2019

(Unaudited)

g) Stock-based Compensation

Stock-based compensation is accounted for at fair value in accordance with ASC 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

h) Income Taxes

Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.

i) Basic and Diluted Net Loss per Share

The Company computes net loss per share in accordance with ASC 105,”Earnings per Share”. ASC 105 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement.

Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period. Diluted EPS excludes all potentially dilutive shares if their effect is anti-dilutive.

j) Professional fees

With the exception of accounting fees and audit fees, substantially all professional fees presented in the financial statements represent hours of work performed by the Court appointed Receiver and his staff to help the Company emerge from Receivership by obtaining external financing. The fees are expensed as incurred as a liability of the Company and the reimbursement of these fees incurred by Receiver is dependent on the amount of financing obtained.

k) Fiscal Periods

The Company’s fiscal year end is July 31.

3. PREFERRED AND COMMON STOCK

On August 8, 2018, the Board of Directors of the Company approved the amendment and restatement of the Company’s Articles of Incorporation. The purpose of the amendment and restatement of the Articles of Incorporation was to:

(i)

Increase the number of authorized shares of Common Stock to 500,000,000;

(ii)

Increase the number of authorized shares of Preferred Stock to 50,000,000;

(iii)

Grant the Board of Directors the rights to designate classes of preferred stock, and to define the powers, preferences, rights, and restrictions thereof;

The preferred and common stock has a par value of $ 0.001 per share.

On August 8, 2018, the Company issued 4 shares of Series A Preferred Stock to the Company’s controlling shareholder, The Oz Corporation, a California corporation.

Table of Contents

BAKHU HOLDINGS, CORP.

Notes to The Financial Statements

January 31, 2019

(Unaudited)

4. INCOME TAXES

As of January 31, 2019, the Company had net operating loss carry forwards of approximately $428,000 that may be available to reduce future years’ taxable income through 2029. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

5. RELATED PARTY TRANSACTIONS

At various times, the Company’s Receiver extended short term financing to the Company at an interest rate of 15%. Due to the nature of the Receiver’s business, sometimes the accrued interest due to the Receiver is not reimbursed. As of January 31, 2019 and July 31, 2018 the Company’s Receiver had extended $8,829 and $8,829, respectively, in short term borrowings to the Company. These borrowings were incurred to help the Company pay for certain expenses associated with the Company’s Receivership status.

The Company’s controlling shareholder, The OZ Corporation, paid for certain expenses associated with the operations of the business. These short term loans to the Company carry an interest rate of 0%. As of January 31, 2019 and July 31, 2018 The OZ Corporation had extended $121,863 and $-0-, respectively, in short term borrowings to the Company.

6. NOTES PAYABLE

The following tables set forth the components of the Company’s short term notes payable at January 31, 2019 and July 31, 2018:

		January 31, 2019		July 31, 2018
Principal value of promissory notes	$	—	$	—
Loan discounts		—		—
Total promissory notes, net	$	—	$	—

In order to maintain and preserve the assets of Bakhu, the Company, pursuant to a filing ’in Nevada’s Eighth Judicial District in Case #A-15-720990-C, the Company sold a $50,000 face value Promissory Note and received $25,000 in proceeds. Under the terms of the Promissory Note, the Note will be paid in full upon the sale of the Company or any other transaction that would involve the issuance of more than 50% of the Company’s securities. This Promissory Note a priority secured lien with conversion into 51% of the Company’s outstanding securities if a change of control transaction resulting in the $50,000 payout does not occur by October 16, 2018.

The Company recorded the $25,000 difference between the face value of the Note and the amount that was funded of $25,000 as debt discount and is being amortized as interest expense over one-year period. The Company did not assign any value to the conversion feature of the Note because the 51% of the common stock of the Company had a negative book value of as of April 30, 2018 and continues to have a negative book value.

During the year ended July 31, 2018, the Company recorded $20,360 in interest expense from the amortization of debt discount.

7 . SUBSEQUENT EVENTS

On December 20, 2018, the Company entered into a License Agreement with Cell Science, Ltd. (CSH”). Pursuant to the License Agreement, the Company is being granted an exclusive license by CSH with respect to certain patents and intellectual property for the production of phytocannabinoids for use in medical treatments and in exchange for 210,000,000 shares of common stock of the Company. The stock was not issued until February 2019 and thus the transaction will be recorded in the financial statements during the quarter ended April 30, 2019.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation

The following discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to future events or our future performance. Actual results may materially differ from those projected in the forward-looking statements as a result of certain risks and uncertainties set forth in this prospectus. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual results will not be different from expectations expressed in this report.

BUSINESS OVERVIEW

We were organized in the State of Nevada on April 24, 2008 under the name Planet Resources, Corp. The Company’s initial business model was the re-processing of mine tailings from previous mining operations. To date we have not generated any revenues because we were not successful in implementing our business plan. Various alternatives were considered to ensure the viability and solvency of the Company; however, the Company went dormant from April 30, 2011 to June, 2018, and in Case Number A-14-720990-C, Nevada's 8th Judicial District appointed Robert Stevens as Receiver for the Company on August 20, 2015. Subsequent to Mr. Stevens being released as the court-appointed receiver in July, 2018, the Company embarked on a new business plan. The Company plans to exploit licenses that it acquires in the bio-pharmacy (Bio-Pharm) field, specifically in the cell-extraction sector. Such products are usually currently focused on medical products for pain relief and insomnia. A growing emphasis is being placed on more serious medical issues, such epilepsy, eye disease, as well as various nerve and vital organ disorders. Also, there is a national imperative to replace the widespread use (and mis-use) of opioids to treat many common ailments. The plans to test the licensed processes in a scientific laboratory setting, prove-up the efficiencies of the extraction process, determine the market value of the process and then license the process for cash consideration and royalty payments.

On December 20, 2018 the Company entered into a License Agreement (the “License Agreement”) with Cell Science Holding, Ltd. (“CSH”). Pursuant to the proposed License Agreement, we will be granted by CSH, a North American exclusive license to certain patents and intellectual property and associated technical information with respect to the production of phytocannabinoids for use in medical treatments in exchange for 210,000,000 shares of the Company’s common stock. These shares were issued in February 2019.

General and administrative expenses have been comprised of administrative wages and benefits; occupancy and office expenses; outside legal, accounting and other professional fees; travel and other miscellaneous office and administrative expenses. Selling and marketing expenses include selling/marketing wages and benefits, advertising and promotional expenses, as well as travel and other miscellaneous related expenses.

Because we have incurred losses, income tax expenses are immaterial. No tax benefits have been booked related to operating loss carryforwards, given our uncertainty of being able to utilize such loss carryforwards in future years. We anticipate incurring additional losses during the coming year.

RESULTS OF OPERATION

Following is management’s discussion of the relevant items affecting results of operations for the three and six months ended January 31, 2019 and 2018.

Revenues . The Company generated no net revenues during the six months ended January 31, 2019 and 2018. We expect revenues to increase as we continue to pursue funding through investment and the application for lines of credit with financial institutions.

Professional and Consulting Fees. Professional and consulting fees were $-0- and $26,170 for the three months ended January 31, 2019 and 2018, respectively. Professional and consulting fees were $83,155 and $106,890 for the six months ended January 31, 2019 and 2018, respectively. With the exception of accounting fees and audit fees, substantially all professional fees presented in the financial statements represent hours of work performed by the Court appointed Receiver and his staff to help the Company emerge from Receivership by obtaining external financing. The fees are expensed as incurred. The Company expects professional fees to increase in the future due to the fees associated with the Company filings with the Securities and Exchange Commission.

Table of Contents

Selling, General and Administrative Expenses . Selling, general and administrative expenses were $-0- and $2,350 for the three months ended January 31, 2019 and 2018, respectively. Selling, general and administrative expenses were $38,847 and $1,726 for the six months ended January 31, 2019 and 2018, respectively. The Company expects SG&A expenses will increase commensurate with an increase in our operations and as a result of the License Agreement with Cell Science Holding.

Other Income (Expenses). The Company had net other expenses of $334 for the three months ended January 31, 2019 compared to net other expense of $6,625 for the three months ended January 31, 2018. The Company had net other expenses of $668 for the six months ended January 31, 2019 compared to net other expense of $7,890 for the six months ended January 31, 2018. Other expenses incurred were comprised of interest expenses related to short term borrowings of the Company.

Net Loss. The Company had a net loss of $334 for the three months ended January 31, 2019 compared to $35,145 for the three months ended January 31, 2018. The Company had a net loss of $122,670 for the six months ended January 31, 2019 compared to $116,506 for the six months ended January 31, 2018. The increase in net loss was mainly due to the increased general and administrative expenses associated with the License Agreement.

LIQUIDITY AND CAPITAL RESOURCES

As of January 31, 2019, our primary source of liquidity consisted of $-0- in cash and cash equivalents. Since inception, we have financed our operations through a combination of short and long-term loans, and through the private placement of our common stock.

We do not believe that the Company’s current capital resources will be sufficient to fund its operating activity and other capital resource demands during the next year. Our ability to continue as a going concern is contingent upon our ability to obtain capital through the sale of equity or issuance of debt, and ultimately attaining profitable operations. We expect that any financing we receive will be similar to what we have heretofore received over the previous two years to enable us to operate, which financing consists of long-term loans at negotiated rates of interest. We cannot assure you that we will be able to successfully complete any of these activities.

We are presently seeking additional debt and equity financing to provide sufficient funds for payment of obligations incurred and to fund our ongoing business plan. We expect to generate revenue pursuant to our new business plan. We cannot assure you, however, that any such financings will be available or will otherwise be made on terms acceptable to us, or that our present shareholders might suffer substantial dilution as a result.

For the six months ended January 31, 2019, cash decreased $13,138 from $13,138 at July 31, 2018 to $-0- at January 31, 2019.

Net cash used in operating activities was $135,001 during the six months ended January 31, 2019, with a net loss of $122,670, which was offset by a decrease in accounts payable of $13,000 and an increase in accrued liabilities of $669.

During the six months ended January 31, 2019, the Company had no net cash flows from investing activities.

During the six months ended January 31, 2019, the Company had $121,863 in net cash provided by financing activities which consisted solely of proceeds from short term borrowings – related parties.

CRITICAL ACCOUNTING PRONOUNCEMENTS

Our financial statements and related public financial information are based on the application of generally accepted accounting principles in the United States (“GAAP”). GAAP requires the use of estimates, assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively

Table of Contents

applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.

Our significant accounting policies are summarized in Note 2 of our financial statements included in our July 31, 2018 Form 10-K. While all of these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates. Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause a material effect on our results of operations, financial position or liquidity for the periods presented in this report.

RECENT ACCOUNTING PRONOUNCEMENTS

We have reviewed accounting pronouncements issued during the past two years and have adopted any that are applicable to the Company. We have determined that none had a material impact on our financial position, results of operations, or cash flows for the periods presented in this report.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as “special purpose entities” (“SPE”s).

Item 3. Quantitative and Qualitative Disclosures about Market Risks

Not applicable because we are a smaller reporting company.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure as a result of continuing material weaknesses (such as the absence of an audit committee and absence of qualified independent directors) in its internal control over financial reporting.

Changes in Internal Controls Over Financial Reporting

There have been no changes in the Company's internal control over financial reporting during the latest fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

Currently we are not aware of any litigation pending or threatened by or against the Company.

Item 1A. Risk Factors

Not applicable because we are a smaller reporting company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information.

None.

Table of Contents

Item 6. Exhibits.

Exhibit No.		Description
3.1		Amended and Restated Articles of Incorporation of Bakhu Holdings Corp.
3.2		Amended and Restated Bylaws of Bakhu Holdings Corp.
31.1		Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Bakhu Holdings Corp.

Date: March 25, 2019	By:	/s/ Tom Emmitt
		Tom Emmitt
		Chief Executive Officer
		(Duly Authorized Officer and Principal Executive Officer)